Fangda Partners

Fangda Partners is particularly effective at advising PRC issuers across a range of core ECM work, as well as in the context of public M&A. In this context, the firm is able to draw from a strong grounding in regulatory issues ensuring that complex transactional work is effectively handled, and also that listed clients are able to receive ongoing compliance work on an ad-hoc basis. Team head Colin Law is the driving force behind the firm’s IPO practice and is particularly adept at handling listings within the biotech space.